Olema Pharmaceuticals, Inc. (OLMA)
30.66
+4.08
(+15.35%)
USD |
NASDAQ |
Dec 10, 16:00
30.60
-0.06
(-0.20%)
After-Hours: 20:00
Olema Pharmaceuticals Shareholders Equity (Quarterly): 307.49M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | 92.80B |
| Replimune Group, Inc. | 263.34M |
| Alnylam Pharmaceuticals, Inc. | 233.89M |
| Insmed, Inc. | 945.57M |
| Altimmune, Inc. | 185.60M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 352.45M |
| Total Liabilities (Quarterly) | 44.96M |
| Debt to Equity Ratio | 0.0146 |
| Current Ratio | 8.026 |
| Net Debt Paydown Yield | -0.07% |